The newly established Christian Doppler Laboratory is dedicated to researching chronic inflammatory processes associated with peritoneal dialysis. The aim of the research is to improve the long-term use of this gentle alternative to haemodialysis and to be able to offer patients this form of treatment for as long as possible, tailored to their individual needs.
Programme
Welcome
- Michaela Fritz
Vice Rector for Research and Innovation of the Medical University Vienna - Martin Gerzabek
President of the Christian Doppler Research Association
Presentation of the Christian Doppler Laboratory for Peritoneal Regulation of the Immune-Metabolic Ecosystem in Peritoneal Dialysis (PRIME-PD)
- Rebecca Herzog
Head of the CD-Laboratory, Department of Pediatrics and Adolescent Medicine, Division of Pediatric Nephrology and Gastroenterology, Medical University Vienna - Bernhard Zinner
CEO Zytoprotec FlexCo - Andreas Vychytil
Department of Medicine III, Division of Nephrology and Dialysis, Medical University Vienna - Christoph Aufricht
Department of Pediatrics and Adolescent Medicine, Head of Division of Pediatric Nephrology and Gastroenterology, Medical University Vienna
Get-together
Registration
Please register by 13th May 2026.
Partners
In Christian Doppler Laboratories, application oriented basic research is pursued at a high level, and expert scientists cooperate with innovative companies. The Christian Doppler Research Association is an international best practice example for promoting this collaboration.
Christian Doppler Laboratories are financed jointly by the public purse and the participating companies. The most important public sponsor is the Federal Ministry of Economy, Energy and Tourism (BMWET).
Zytoprotec is a Vienna-based biotechnology compa ny specializing in the development of innovative the rapies for peritoneal dialysis. The company focuses on harnessing cellular stress responses and immu nometabolic mechanisms to significantly improve the survival of patients with kidney failure.